The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy

IF 1.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Endocrinology & Metabolism Pub Date : 2024-05-23 DOI:10.1097/XCE.0000000000000304

Juhi K. Gupta, Rathi Ravindrarajah, G. Tilston, Wiliam Ollier, Darren M. Ashcroft, Adrian H. Heald

引用次数: 0

查看原文本刊更多论文

2型糖尿病患者的多重用药与COVID-19结果之间的关联（与合并症无关）：多重用药的不可预见后果的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Endocrinology & Metabolism CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.60

自引率

0.00%

发文量